Article Details
Retrieved on: 2024-09-04 19:16:01
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the projected growth of the canine atopic dermatitis treatment market, driven by advancements in biopharma, such as monoclonal antibodies. Tags like 'Type I hypersensitivity' and 'Immunoglobulin E' highlight key aspects of the disease's immune response.
Article found on: marketresearchblog.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here